Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 2
1967 7
1968 6
1969 6
1970 4
1971 6
1972 2
1973 4
1974 3
1975 8
1976 4
1977 5
1978 3
1979 9
1980 6
1981 4
1982 9
1983 5
1984 7
1985 4
1986 5
1987 7
1988 7
1989 17
1990 13
1991 10
1992 6
1993 12
1994 6
1995 8
1996 5
1997 8
1998 5
1999 14
2000 9
2001 11
2002 4
2003 9
2004 6
2005 3
2006 9
2007 7
2008 9
2009 7
2010 5
2011 6
2012 7
2013 5
2014 5
2015 5
2016 6
2017 2
2018 1
2019 1
2020 2
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

327 results
Results by year
Filters applied: . Clear all
Page 1
Combined oral contraceptives in women with systemic lupus erythematosus.
Petri M, Kim MY, Kalunian KC, Grossman J, Hahn BH, Sammaritano LR, Lockshin M, Merrill JT, Belmont HM, Askanase AD, McCune WJ, Hearth-Holmes M, Dooley MA, Von Feldt J, Friedman A, Tan M, Davis J, Cronin M, Diamond B, Mackay M, Sigler L, Fillius M, Rupel A, Licciardi F, Buyon JP; OC-SELENA Trial. Petri M, et al. N Engl J Med. 2005 Dec 15;353(24):2550-8. doi: 10.1056/NEJMoa051135. N Engl J Med. 2005. PMID: 16354891 Free article. Clinical Trial.
METHODS: A total of 183 women with inactive (76 percent) or stable active (24 percent) systemic lupus erythematosus at 15 U.S. sites were randomly assigned to receive either oral contraceptives (triphasic ethinyl estradiol at a dose of 35 microg plus norethindron
METHODS: A total of 183 women with inactive (76 percent) or stable active (24 percent) systemic lupus erythematosus at 15 U.S. sites were ra …
Randomized Controlled Trial of Preconception Interventions in Infertile Women With Polycystic Ovary Syndrome.
Legro RS, Dodson WC, Kris-Etherton PM, Kunselman AR, Stetter CM, Williams NI, Gnatuk CL, Estes SJ, Fleming J, Allison KC, Sarwer DB, Coutifaris C, Dokras A. Legro RS, et al. J Clin Endocrinol Metab. 2015 Nov;100(11):4048-58. doi: 10.1210/jc.2015-2778. Epub 2015 Sep 24. J Clin Endocrinol Metab. 2015. PMID: 26401593 Free PMC article. Clinical Trial.
INTERVENTION: Women were randomly assigned to receive either 16 weeks of 1) continuous oral contraceptive pills (OCPs) (ethinyl estradiol 20 mcg/1 mg norethindrone acetate) ("OCP"); 2) lifestyle modification consisting of caloric restriction with meal replace …
INTERVENTION: Women were randomly assigned to receive either 16 weeks of 1) continuous oral contraceptive pills (OCPs) (ethinyl es
Pharmacokinetic and Drug-Drug Interaction Profiles of the Combination of Tezacaftor/Ivacaftor.
Garg V, Shen J, Li C, Agarwal S, Gebre A, Robertson S, Huang J, Han L, Jiang L, Stephan K, Wang LT, Lekstrom-Himes J. Garg V, et al. Clin Transl Sci. 2019 May;12(3):267-275. doi: 10.1111/cts.12610. Epub 2019 Jan 29. Clin Transl Sci. 2019. PMID: 30694595 Free PMC article. Clinical Trial.
The effects of steady-state tezacaftor/ivacaftor on the pharmacokinetics (PKs) of digoxin (a P-gp substrate), midazolam, and ethinyl estradiol/norethindrone (CYP3A substrates) were evaluated. ...Tezacaftor/ivacaftor increased digoxin area under the curve (AUC …
The effects of steady-state tezacaftor/ivacaftor on the pharmacokinetics (PKs) of digoxin (a P-gp substrate), midazolam, and ethinyl
The effect of isotretinoin on the pharmacokinetics and pharmacodynamics of ethinyl estradiol and norethindrone.
Hendrix CW, Jackson KA, Whitmore E, Guidos A, Kretzer R, Liss CM, Shah LP, Khoo KC, McLane J, Trapnell CB. Hendrix CW, et al. Clin Pharmacol Ther. 2004 May;75(5):464-75. doi: 10.1016/j.clpt.2004.01.003. Clin Pharmacol Ther. 2004. PMID: 15116059 Clinical Trial.
RESULTS: The addition of isotretinoin to the oral contraceptive regimen resulted in small and inconsistent, although statistically significant (P <.04), decreases in the concentrations of both ethinyl estradiol (9% decrease in area under the plasma concentration- …
RESULTS: The addition of isotretinoin to the oral contraceptive regimen resulted in small and inconsistent, although statistically significa …
The effect of monophasic combinations of ethinyl estradiol and norethindrone on gonadotropins, androgens and sex hormone binding globulin: a randomized trial.
Moutos D, Smith S, Zacur H. Moutos D, et al. Contraception. 1995 Aug;52(2):105-9. doi: 10.1016/s0010-7824(95)00137-9. Contraception. 1995. PMID: 8536446 Clinical Trial.
Dehydroepiandrosterone sulfate was suppressed to a similar degree with ethinyl estradiol 35 micrograms/norethindrone 1 mg and ethinyl estradiol 35 micrograms/norethindrone 0.5 mg, but ethinyl estradiol 50 micrograms/noret
Dehydroepiandrosterone sulfate was suppressed to a similar degree with ethinyl estradiol 35 micrograms/norethindrone 1 …
Norethindrone acetate 1.0 milligram and ethinyl estradiol 10 micrograms as an ultra low-dose oral contraceptive.
Archer DF, Nakajima ST, Sawyer AT, Wentworth J, Trupin S, Koltun WD, Gilbert RD, Ellman H. Archer DF, et al. Obstet Gynecol. 2013 Sep;122(3):601-7. doi: 10.1097/AOG.0b013e3182a1741c. Obstet Gynecol. 2013. PMID: 23921878 Clinical Trial.
METHODS: This open-label, uncontrolled, multicenter study used an ultra low-dose OCP (1.0 mg norethindrone acetate and 10 micrograms ethinyl E2). The OCP was administered in a regimen of 24 days of a 28-day cycle followed by 10 micrograms ethinyl E2 for 2 day …
METHODS: This open-label, uncontrolled, multicenter study used an ultra low-dose OCP (1.0 mg norethindrone acetate and 10 micrograms …
Minimal androgenic activity of a new oral contraceptive containing norethindrone acetate and graduated doses of ethinyl estradiol.
Boyd RA, Zegarac EA, Posvar EL, Flack MR. Boyd RA, et al. Contraception. 2001 Feb;63(2):71-6. doi: 10.1016/s0010-7824(01)00179-2. Contraception. 2001. PMID: 11292470 Clinical Trial.
The pharmacokinetics and androgenic activity of Estrostep, a new oral contraceptive providing low-dose estrogen in a graduated sequence with a constant dose of progestin, were characterized in an open-label, nonrandomized study in 17 normally cycling women treated for three cycle …
The pharmacokinetics and androgenic activity of Estrostep, a new oral contraceptive providing low-dose estrogen in a graduated sequence with …
Hormonal contraception alters vaginal microbiota and cytokines in South African adolescents in a randomized trial.
Balle C, Konstantinus IN, Jaumdally SZ, Havyarimana E, Lennard K, Esra R, Barnabas SL, Happel AU, Moodie Z, Gill K, Pidwell T, Karaoz U, Brodie E, Maseko V, Gamieldien H, Bosinger SE, Myer L, Bekker LG, Passmore JS, Jaspan HB. Balle C, et al. Nat Commun. 2020 Nov 4;11(1):5578. doi: 10.1038/s41467-020-19382-9. Nat Commun. 2020. PMID: 33149114 Free PMC article. Clinical Trial.
To investigate this, 130 HIV negative adolescent females aged 15-19 years were enrolled into a substudy of UChoose, an open-label randomized crossover study (NCT02404038), comparing acceptability and contraceptive product preference as a proxy for HIV prevention delivery methods. …
To investigate this, 130 HIV negative adolescent females aged 15-19 years were enrolled into a substudy of UChoose, an open-label randomized …
The effect of food on the bioavailability of norethindrone and ethinyl estradiol from norethindrone acetate/ethinyl estradiol tablets intended for continuous hormone replacement therapy.
Boyd RA, Zegarac EA, Eldon MA. Boyd RA, et al. J Clin Pharmacol. 2003 Jan;43(1):52-8. doi: 10.1177/0091270002239706. J Clin Pharmacol. 2003. PMID: 12520628 Clinical Trial.
As part of the development of a combination product containing norethindrone acetate and low-dose ethinyl estradiol for continuous hormone replacement therapy in postmenopausal women, a study was conducted to determine the effect of a high-fat meal on the bio …
As part of the development of a combination product containing norethindrone acetate and low-dose ethinyl estradiol for …
Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy.
Simon JA, Liu JH, Speroff L, Shumel BS, Symons JP. Simon JA, et al. Am J Obstet Gynecol. 2003 Jan;188(1):92-9. doi: 10.1067/mob.2003.104. Am J Obstet Gynecol. 2003. PMID: 12548201 Clinical Trial.
OBJECTIVE: The purpose of this study was to compare the effects on vaginal bleeding patterns of continuous combined hormone replacement therapy with norethindrone acetate and ethinyl estradiol versus conjugated equine estrogens and medroxyprogesterone acetate …
OBJECTIVE: The purpose of this study was to compare the effects on vaginal bleeding patterns of continuous combined hormone replacement ther …
327 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page